Developing vaccines to trigger immune responses against HIV
Design and testing of germline-targeting and boosting immunogens to elicit 10E8-like broadly neutralizing antibodies against HIV
This study is working on a new way to help your immune system make stronger defenses against HIV by creating special vaccines that encourage your body to produce powerful antibodies, which could lead to a better HIV vaccine for everyone.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Scripps Research Institute, the NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-10655514 on NIH RePORTER |
What this research studies
This research focuses on creating and testing new immunogens designed to stimulate the immune system to produce broadly neutralizing antibodies (bnAbs) against HIV. By targeting specific germline precursors of these antibodies, the study aims to activate B-cells that can evolve into effective HIV fighters. The approach involves engineering immunogens using advanced computational design and directed evolution techniques to ensure they can effectively engage the immune system without causing harmful reactions. Patients may benefit from this innovative strategy as it could lead to a more effective HIV vaccine.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of HIV infection who are interested in participating in vaccine trials.
Not a fit: Patients who are already HIV-positive or those who have a history of severe allergic reactions to vaccines may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of a groundbreaking HIV vaccine that provides broad protection against the virus.
How similar studies have performed: Previous research has shown promise in developing vaccines that induce broadly neutralizing antibodies, making this approach a continuation of ongoing efforts in the field.
Where this research is happening
La Jolla, United States
- Scripps Research Institute, the — La Jolla, United States (Active)
Researchers
- Principal investigator: Schief, William R. — Scripps Research Institute, the
- Study coordinator: Schief, William R.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.